BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37080629)

  • 1. Long-term impact on cardiopulmonary function and quality of life among patients recovered from SARS-CoV-2 infection in a 6-month follow-up period in Lima, Peru: FUNCTION cohort study protocol.
    Cachay R; Watanabe-Tejada T; Cuno K; Gil-Zacarias M; Coombes C; Ballena I; Mejia F; Medina F; Gayoso O; Seas C; Otero L; Gotuzzo E
    BMJ Open; 2023 Apr; 13(4):e067365. PubMed ID: 37080629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-Up Analysis of Pulmonary Function, Exercise Capacity, Radiological Changes, and Quality of Life Two Months after Recovery from SARS-CoV-2 Pneumonia.
    Strumiliene E; Zeleckiene I; Bliudzius R; Samuilis A; Zvirblis T; Zablockiene B; Strumila A; Gruslys V; Malinauskiene L; Kasiulevicius V; Jancoriene L
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204878
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of socioeconomic status on functional recovery after ARDS caused by SARS-CoV-2: a multicentre, observational study.
    Declercq PL; Fournel I; Demeyere M; Ksiazek E; Meunier-Beillard N; Rivière A; Clarot C; Maizel J; Schnell D; Plantefeve G; Ampere A; Daubin C; Sauneuf B; Kalfon P; Federici L; Redureau É; Bousta M; Lagache L; Vanderlinden T; Nseir S; La Combe B; Bourdin G; Monchi M; Nyunga M; Ramakers M; Oulehri W; Georges H; Salmon Gandonniere C; Badie J; Delbove A; Monnet X; Beduneau G; Artaud-Macari É; Abraham P; Delberghe N; Le Bouar G; Miailhe AF; Hraiech S; Bironneau V; Sedillot N; Hoppe MA; Barbar SD; Calcaianu GD; Dellamonica J; Terzi N; Delpierre C; Gélinotte S; Rigaud JP; Labruyère M; Georges M; Binquet C; Quenot JP;
    BMJ Open; 2022 Apr; 12(4):e057368. PubMed ID: 35459672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months.
    Steinbeis F; Thibeault C; Doellinger F; Ring RM; Mittermaier M; Ruwwe-Glösenkamp C; Alius F; Knape P; Meyer HJ; Lippert LJ; Helbig ET; Grund D; Temmesfeld-Wollbrück B; Suttorp N; Sander LE; Kurth F; Penzkofer T; Witzenrath M; Zoller T
    Respir Med; 2022 Jan; 191():106709. PubMed ID: 34871947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol.
    Mera-Cordero F; Bonet-Monne S; Almeda-Ortega J; García-Sangenís A; Cunillera-Puèrtolas O; Contreras-Martos S; Alvarez-Muñoz G; Monfà R; Balanzo-Joué M; Morros R; Salvador-Gonzalez B
    Trials; 2022 Jan; 23(1):19. PubMed ID: 34991703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of Ayurvedic interventions and Yoga on long term effects of COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Yadav B; Rai A; Mundada PS; Singhal R; Rao BCS; Rana R; Srikanth N
    Trials; 2021 Jun; 22(1):378. PubMed ID: 34082792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge.
    Bellan M; Soddu D; Balbo PE; Baricich A; Zeppegno P; Avanzi GC; Baldon G; Bartolomei G; Battaglia M; Battistini S; Binda V; Borg M; Cantaluppi V; Castello LM; Clivati E; Cisari C; Costanzo M; Croce A; Cuneo D; De Benedittis C; De Vecchi S; Feggi A; Gai M; Gambaro E; Gattoni E; Gramaglia C; Grisafi L; Guerriero C; Hayden E; Jona A; Invernizzi M; Lorenzini L; Loreti L; Martelli M; Marzullo P; Matino E; Panero A; Parachini E; Patrucco F; Patti G; Pirovano A; Prosperini P; Quaglino R; Rigamonti C; Sainaghi PP; Vecchi C; Zecca E; Pirisi M
    JAMA Netw Open; 2021 Jan; 4(1):e2036142. PubMed ID: 33502487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact on Mental, Physical and Cognitive functioning of a Critical care sTay during the COVID-19 pandemic (IMPACCT COVID-19): protocol for a prospective, multicentre, mixed-methods cohort study.
    Castro-Ávila AC; Merino-Osorio C; González-Seguel F; Camus-Molina A; Leppe J;
    BMJ Open; 2021 Sep; 11(9):e053610. PubMed ID: 34497087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
    Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
    Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.